Acrongenomics, Inc.

Acrongenomics signs $6.5M agreement with Molecular Vision

Published in Medical Device Business Week, June 21st, 2006

Acrongenomics, Inc., (AGNM) and Molecular Vision, Ltd., an Imperial Innovations spin-off company, announced a joint collaboration intended to accelerate the development and commercialization of low-cost, easy-to-use and readily portable point-of-care (POC) diagnostic devices for personalized medical testing that will greatly extend the tools available to the medical community.

The project outlined in the collaboration is intended to support the development of novel POC devices for on-the-spot diagnosis of diabetes management, STDs (Sexually Transmitted Diseases), cardiovascular diseases and substances of abuse, based on the BioLED technology developed by the Molecular...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Device Business Week

Source: Medical Device Business Week (2006-06-21)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry